01 1Curia New York, Inc.
02 1Honour Lab Limited
03 1Sionc Pharmaceutical Private Limited
04 1Vasudha Pharma Chem Limited
01 3Diatrizoate Sodium
02 1diatrizoate sodium
01 3India
02 1U.S.A
NDC Package Code : 65392-1701
Start Marketing Date : 1954-11-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (65kg/65kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69037-0052
Start Marketing Date : 1982-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76055-0014
Start Marketing Date : 2019-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66577-032
Start Marketing Date : 2018-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Meglumine sodium amidotrizoate injection manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Meglumine sodium amidotrizoate injection, including repackagers and relabelers. The FDA regulates Meglumine sodium amidotrizoate injection manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Meglumine sodium amidotrizoate injection API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Meglumine sodium amidotrizoate injection manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Meglumine sodium amidotrizoate injection supplier is an individual or a company that provides Meglumine sodium amidotrizoate injection active pharmaceutical ingredient (API) or Meglumine sodium amidotrizoate injection finished formulations upon request. The Meglumine sodium amidotrizoate injection suppliers may include Meglumine sodium amidotrizoate injection API manufacturers, exporters, distributors and traders.
click here to find a list of Meglumine sodium amidotrizoate injection suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Meglumine sodium amidotrizoate injection as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Meglumine sodium amidotrizoate injection API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Meglumine sodium amidotrizoate injection as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Meglumine sodium amidotrizoate injection and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Meglumine sodium amidotrizoate injection NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Meglumine sodium amidotrizoate injection suppliers with NDC on PharmaCompass.
We have 4 companies offering Meglumine sodium amidotrizoate injection
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
